Delivery Order SPE2DB20D1100-SPE2DB24FD7V0

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Zepbound 5 mg/0.5 ml pens. The $4,215.04 firm-fixed-price delivery order contract has an ultimate completion date of August 28, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for the company to...
The Defense Logistics Agency (DLA) awarded a $1,388 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Zepbound 5 mg/0.5 ml pens. The contract has an ultimate completion date of March 14, 2024 and is not designated with a set-aside requirement, indicating open competition. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
The federal contract award details a $1,404.79 delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Zepbound 7.5 mg/0.5 ml pens, a medical product used for various healthcare applications. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Zepbound 5 mg/0.5 ml pens, with an ultimate completion date of June 26, 2025 and a ceiling value of $9,557.52. The contract is a Firm Fixed Price Delivery Order, and it is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,736.61 firm fixed-price delivery order is for the ZEPBOUND 10 MG/0.5 ML PEN 0.5ML medical product. The contract has an ultimate completion date of July 8, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
The federal contract award, valued at $9,551.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables DLA to efficiently procure essential pharmaceutical and medical supplies from Amerisourcebergen to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zepbound 12.5 mg/0.5 ml pens in 0.5 ml quantities, with a ceiling value of $38,254.26. The contract is a firm-fixed-price delivery order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,625.80 delivery order contract is for the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.8ML medical products. The contract has a firm fixed price pricing type and an ultimate completion date of March 7, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,586.44 firm fixed-price delivery order contract is for the supply of "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" medical products. The contract has an ultimate completion date of February 3, 2025. While the original solicitation was not provided, the award indicates that this is part of a larger Indefinite...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 7.5 mg/0.5 mL ZEPBOUND pens with a ceiling value of $5,111.96 and a performance period ending on May 23, 2025. This contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD7V0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Zepbound 10 mg/0.5 ml pens. The contract has a firm fixed price of $1,474.20 and a completion date of September 12, 2024. This is a delivery order contract, which is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/11/24, 9:09 AM